علاج دوالي المريء مع النزيف في ارتفاع ضغط الباب غير التليفي مع تضخم الطحال الكبير

References

DOI: 10.1007/s12072-025-10894-4

• Absence of ascites, jaundice, and hepatic encephalopathy, and presence of large splenomegaly are the clinical clues in differentiating NCPH from cirrhotic portal hypertension (CPHT).
• First-line treatment options are essentially the same as in cirrhosis patients.
• Vasoactive drugs, such as somatostatin, octreotide, or terlipressin have been used in the treatment of AVB while endoscopic therapy is being arranged.
• At present, band ligation is preferred owing to lower complication rates.
• Antibiotics are not recommended in AVB in NCPF, unless absolute neutrophil count is <1,000 mm⁻³.